Elicio Therapeutics, Inc. (ELTX) › RevenueElicio Therapeutics, Inc. (ELTX) — RevenueAnnual figures by fiscal year, from SEC filings.2020: $2.88M2021: $28.31M2022: $2.30M$2.30M2020Revenue (USD)2022Fiscal YearRevenueChange YoY2022$2.30M-91.9%2021$28.31M+883.1%2020$2.88M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share